心衰加重如何处理?来看看最新中国专家共识

2022-06-23 中国循环杂志 中国循环杂志

一睹为快~

我国心力衰竭患病率持续升高,心衰患者的高死亡率、高住院率带来巨大的公共卫生负担。心衰加重与慢性心衰患者的死亡和再住院密切相关。近年来预防管理心衰加重领域有不少新观念和新进展,由中国老年医学学会心电及心功能分会,中国医师协会心血管内科分会,中国心衰中心联盟专家委员会共同组织专家,根据国内外最新临床研究,参考相关指南,结合我国国情及临床实践,撰写本共识,从慢性心衰加重的定义、诊断与评估、治疗、预防和管理等方面进行介绍,为临床医师早期识别和治疗慢性心衰加重患者提供参考。

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1845930, encodeId=f2591845930a6, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 15 19:13:54 CST 2023, time=2023-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741687, encodeId=38ee1e41687a9, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Fri Feb 24 12:13:54 CST 2023, time=2023-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736467, encodeId=dbf61e364678d, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Mon Feb 20 14:13:54 CST 2023, time=2023-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228342, encodeId=cd1112283426a, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Fri Jun 24 06:38:46 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1845930, encodeId=f2591845930a6, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 15 19:13:54 CST 2023, time=2023-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741687, encodeId=38ee1e41687a9, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Fri Feb 24 12:13:54 CST 2023, time=2023-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736467, encodeId=dbf61e364678d, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Mon Feb 20 14:13:54 CST 2023, time=2023-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228342, encodeId=cd1112283426a, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Fri Jun 24 06:38:46 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1845930, encodeId=f2591845930a6, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 15 19:13:54 CST 2023, time=2023-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741687, encodeId=38ee1e41687a9, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Fri Feb 24 12:13:54 CST 2023, time=2023-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736467, encodeId=dbf61e364678d, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Mon Feb 20 14:13:54 CST 2023, time=2023-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228342, encodeId=cd1112283426a, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Fri Jun 24 06:38:46 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2023-02-20 贵阳
  4. [GetPortalCommentsPageByObjectIdResponse(id=1845930, encodeId=f2591845930a6, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 15 19:13:54 CST 2023, time=2023-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741687, encodeId=38ee1e41687a9, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Fri Feb 24 12:13:54 CST 2023, time=2023-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736467, encodeId=dbf61e364678d, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Mon Feb 20 14:13:54 CST 2023, time=2023-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228342, encodeId=cd1112283426a, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Fri Jun 24 06:38:46 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2022-06-24 学医无涯

    学习一下

    0

相关资讯

重磅!欧唐静®(恩格列净片)新适应症在华获批,用于治疗射血分数降低的成人心力衰竭

欧唐静®于2017年首次在中国市场获批,用于治疗成人2型糖尿病患者。

JACC:高血糖大大推进亚临床心衰的进展!

在亚临床心衰的老年人中,控制不佳的糖尿病与心衰进展的高风险密切相关

Eur Heart J:恩格列净对心力衰竭患者血清钾的影响

恩格列净降低了高钾血症的发生率,而低钾血症发生率并没有显著增加。

JACC:还不戒烟吗?吸烟使心力衰竭风险翻倍!

戒烟可显著降低心衰风险,但吸烟造成的高心衰风险可持续数十年

Cardiovasc Diabetol:多种营养生物标志物与糖尿病患者心衰结局的相关性

同型半胱氨酸是T2D患者全因死亡的独立危险因素

Physiotherapy:6分钟步行试验后心率恢复时间延长是心力衰竭心脏事件的独立危险因素

心力衰竭(heart failure)简称心衰,是指由于心脏的收缩功能和(或)舒张功能发生障碍,不能将静脉回心血量充分排出心脏,导致静脉系统血液淤积,动脉系统血液灌注不足。